Psychedelic and ketamine research trials in China
Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.
18 registered studies are counted in China. By compound: 18 ketamine. By registry status: 3 recruiting, 1 not yet recruiting, 1 active, not recruiting, 6 completed and 7 status not reported. By phase: 3 early phase 1, 1 phase 1, 3 phase 2, 3 phase 4 and 8 not applicable. Reported start years run from 2012 (earliest) to 2026 (latest). Studies are linked to 13 institutions.
Country is taken from the research site linked to each registry record. A study counts once, and a study tagged with more than one compound is counted under each compound. Ketamine studies are counted only when PsychoactiveMap classifies them as psychiatric research; anaesthesia, sedation and pain studies are left out.
Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.
Recruiting now
4 of the 18 counted studies are listed in the registry as recruiting (3) or not yet recruiting (1), newest start first. Status is reported by study teams and can be out of date. PsychoactiveMap does not recruit, screen or refer anyone; eligibility and contact details are on each registry record.
| Title as registered | Registry ID | Status | Phase | Start | Institution and city |
|---|---|---|---|---|---|
| The Effect of Intraoperative Infusion of Esketamine on Cholestatic Pruritus in Patients Undergoing Hepatobiliary Surgery | NCT07760740 | Not yet recruiting | Not applicable | 2026-08-15 | Tianjin Medical University General Hospital, Tianjin |
| Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study | NCT07247968 | Recruiting | Early Phase 1 | 2025-11-25 | First Affiliated Hospital of Chongqing Medical University, Chongqing |
| Personalized DBS Targeting for Treating Depression | NCT06784388 | Recruiting | Early Phase 1 | 2025-01-05 | Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou |
| Effect of Subanesthetic Dose of Esketamine on Sleep Quality | NCT06773143 | Recruiting | Not applicable | 2024-12-30 | Nanjing First Hospital, Nanjing Medical University, Nanjing |
At a glance
- 18 registered studies are counted on this page.
By compound
| Compound hub | Studies |
|---|---|
| Ketamine | 18 |
By registry status
| Status | Studies | Share |
|---|---|---|
| Recruiting | 3 | 17% |
| Not yet recruiting | 1 | 6% |
| Active, not recruiting | 1 | 6% |
| Completed | 6 | 33% |
| Status not reported | 7 | 39% |
By phase
| Phase | Studies | Share |
|---|---|---|
| Early Phase 1 | 3 | 17% |
| Phase 1 | 1 | 6% |
| Phase 2 | 3 | 17% |
| Phase 4 | 3 | 17% |
| Not applicable | 8 | 44% |
When studies started
| Start year | Studies |
|---|---|
| 2024 to 2026 | 7 |
| 2020 to 2023 | 8 |
| 2015 to 2019 | 2 |
| 2010 to 2014 | 1 |
All counted studies
All 18 counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.
| Title as registered | Registry ID | Status | Phase | Start | Institution and city |
|---|---|---|---|---|---|
| The Effect of Intraoperative Infusion of Esketamine on Cholestatic Pruritus in Patients Undergoing Hepatobiliary Surgery | NCT07760740 | Not yet recruiting | Not applicable | 2026-08-15 | Tianjin Medical University General Hospital, Tianjin |
| Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study | NCT07247968 | Recruiting | Early Phase 1 | 2025-11-25 | First Affiliated Hospital of Chongqing Medical University, Chongqing |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior | NCT07193901 | Completed | Phase 2 | 2025-05-27 | Sichuan Purity Pharmaceutical Technology Co., Ltd., Beijing |
| Personalized DBS Targeting for Treating Depression | NCT06784388 | Recruiting | Early Phase 1 | 2025-01-05 | Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou |
| Effect of Subanesthetic Dose of Esketamine on Sleep Quality | NCT06773143 | Recruiting | Not applicable | 2024-12-30 | Nanjing First Hospital, Nanjing Medical University, Nanjing |
| Effects of Esketamine on Consciousness-related Brain Network Characteristics in Patients With Prolonged Disorders of Consciousness | NCT06473285 | Status not reported | Not applicable | 2024-06-01 | Beijing Tiantan Hospital, Beijing |
| Esketamine vs ECT for Acute Suicidality | NCT06355180 | Completed | Not applicable | 2024-04-16 | Capital Medical University, Wuhu |
| Effect of Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth | NCT05698394 | Active, not recruiting | Phase 4 | 2023-09-09 | Peking University First Hospital, Changsha |
| The Effectiveness and Safety of Esketamine in Modified Electroconvulsive Therapy | NCT04777110 | Status not reported | Early Phase 1 | 2021-08-01 | First Affiliated Hospital of Chongqing Medical University, Chongqing |
| Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder | NCT04847245 | Status not reported | Not applicable | 2021-05-01 | Peking University, Beijing |
| Esketamine on Postpartum Depression in Cesarean Section Women | NCT04860661 | Completed | Not applicable | 2021-05-01 | Tongji Hospital, Wuhan |
| Esketamine and Perioperative Depressive Symptoms | NCT04425473 | Completed | Phase 2 | 2021-02-19 | Beijing Tiantan Hospital, Beijing |
| The Study on the Esketamine in the Treatment of Postherpetic Neuralgia | NCT04664530 | Status not reported | Phase 4 | 2020-11-25 | Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou |
| The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) | NCT04399070 | Status not reported | Not applicable | 2020-08-01 | West China Hospital, Chengdu |
| Low-dose S-ketamine in Women With Prenatal Depression | NCT04414943 | Completed | Not applicable | 2020-06-19 | Peking University First Hospital, Beijing |
| Ketamine and Postoperative Depressive Symptom-PASSION | NCT03086148 | Completed | Phase 2 | 2017-07-05 | Beijing Tiantan Hospital, Beijing |
| Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy | NCT02305394 | Status not reported | Phase 4 | 2015-01-01 | First Affiliated Hospital of Chongqing Medical University, Chongqing |
| Study of Ketamine as an Antidepressant in Major Depressive Disorder | NCT01573741 | Status not reported | Phase 1 | 2012-02-01 | Jinling Hospital, China, Changzhou |
About this data
Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.
Substance hubs for these compounds
Institution hubs in this country
Institutions in this country with at least 3 counted studies. The number is that institution's own count of studies, which can include studies not shown above if the registry lists them under another country.
- Beijing Tiantan Hospital: 3 studies
- First Affiliated Hospital of Chongqing Medical University: 3 studies
Condition hubs
Condition hubs that include studies counted in this country, with the number of those studies. Conditions are matched by keyword on registered titles, so one study can appear under more than one condition.
| Condition hub | Studies in this country |
|---|---|
| Depression | 12 |
| Suicidal ideation and suicide risk | 2 |
| Bipolar disorder | 1 |
| Treatment-resistant depression | 1 |
Other country hubs
United States | Canada | Switzerland | United Kingdom | France | Israel | Brazil | Netherlands | Australia | Austria | Germany | Spain | Sweden | Argentina | Belgium | Egypt | Mexico | Poland | Taiwan | Ireland | Czech Republic | Denmark | Finland